Clinical Significance of IgG4 Serum Concentration in Graves’ Disease
By:
References
- Aalberse RC, van der Gaag R, van Leeuwen J (1983) Serologic aspects of IgG4 antibodies. I. Prolonged immunization results in an IgG4-restricted response. J Immunol 130:722–726. https://doi.org/10.4049/jimmunol.130.2.722
- Bartalena L, Kahaly GJ, Baldeschi L et al (2021) The 2021 European Group on Graves’ orbitopathy (EUGOGO) clinical practice guidelines for the medical management of Graves’ orbitopathy. Eur J Endocrinol 185:G43–G67. https://doi.org/10.1530/EJE-21-0479
- Bozkirli E, Bakiner OS, Ersozlu Bozkirli ED et al (2015) Serum immunoglobulin G4 levels are elevated in patients with Graves’ ophthalmopathy. Clin Endocrinol 83:962–967. https://doi.org/10.1111/cen.12671
- Comi S, Lanzolla G, Cosentino G et al (2023) IgG4 serum levels in Graves’ orbitopathy. J Endocrinol Invest 47, 1711–1717. https://doi.org/10.1007/s40618-023-02265-3
- Ebbo M, Grados A, Bernit E et al (2012) Pathologies associated with serum IgG4 elevation. Int J Rheumatol 2012:602809. https://doi.org/10.1155/2012/602809
- Elshaer RK, Halawa MR, Ahmed IZ et al (2022) Serum IgG4 level for malignancy prediction in indeterminate thyroid nodules among patients with or without autoimmune thyroid disease. Egypt J Immunol 29:156–162.
- Hiratsuka I, Yamada H, Itoh M et al (2020) Changes in serum immunoglobulin G4 levels in patients with newly diagnosed Graves’ disease. Exp Clin Endocrinol Diabetes 128:119–124. https://doi.org/10.1055/a-0669-9333
- Kamisawa T, Funata N, Hayashi Y et al (2003) A new clinicopathological entity of IgG4-related autoimmune disease. J Gastroenterol 38:982–984. https://doi.org/10.1007/s00535-003-1175-y
- Katz G, Stone JH (2022) Clinical perspectives on IgG4-related disease and its classification. Annu Rev Med 73:545–562. https://doi.org/10.1146/annurev-med-050219-034449
- Koneczny I, Tzartos J, Mané-Damas M et al (2022) IgG4 autoantibodies in organ-specific autoimmunopathies: Reviewing class switching, antibody-producing cells, and specific immunotherapies. Front Immunol 13:834342. https://doi.org/10.3389/fimmu.2022.834342
- Kottahachchi D, Topliss DJ (2016) Immunoglobulin G4-related thyroid diseases. Eur Thyroid J 5:231–239. https://doi.org/10.1159/000452623
- Lang D, Zwerina J, Pieringer H (2016) IgG4-related disease: Current challenges and future prospects. Ther Clin Risk Manag 12: 189–199. https://doi.org/10.2147/TCRM.S99985
- Li Y, Luo B, Zhang J et al (2021) Clinical relevance of serum immunoglobulin G4 in glucocorticoid therapy of Graves’ ophthalmopathy. Clin Endocrinol 95:657–667. https://doi.org/10.1111/cen.14493
- Luo B, Yuan X, Wang W et al (2022) Ocular manifestations and clinical implications of serum immunoglobulin G4 levels in Graves’ ophthalmopathy patients. Ocul Immunol Inflamm 30:580–587. https://doi.org/10.1080/09273948.2020.1826537
- Martin CS, Sirbu AE, Betivoiu MA et al (2017) Serum immunoglobulin G4 levels and Graves’ disease phenotype. Endocrine 55: 478–484. https://doi.org/10.1007/s12020-016-1157-5
- Nowak M, Nowak W, Marek B et al (2024) Differential diagnosis of thyroid orbitopathy — diseases mimicking the presentation or activity of thyroid orbitopathy. Endokrynol Pol 75:1–11. https://doi.org/10.5603/ep.98156
- Olejarz M, Szczepanek-Parulska E, Dadej D et al (2021) IgG4 as a biomarker in graves’ orbitopathy. Mediators Inflamm 10:2021:5590471. https://doi.org/10.1155/2021/5590471
- Olejarz M, Szczepanek-Parulska E, Ostałowska-Klockiewicz A et al (2023) High IgG4 serum concentration is associated with active Graves orbitopathy. Front Endocrinol 14:1083321. https://doi.org/10.3389/fendo.2023.1083321
- Rotondi M, Carbone A, Coperchini F et al (2019) Diagnosis of endocrine disease: IgG4-related thyroid autoimmune disease. Eur J Endocrinol 180:R175–R183. https://doi.org/10.1530/EJE-18-1024
- Sawicka-Gutaj N, Gruszczyński D, Guzik P et al (2022) Publication ethics of human studies in the light of the Declaration of Helsinki – a mini-review. J Med Sci 91:e700. https://doi.org/10.20883/medical.e700
- Sy A, Silkiss RZ (2016) Serum total IgG and IgG4 levels in thyroid eye disease. Int Med Case Rep J 9:325–328. https://doi.org/10.2147/IMCRJ.S116331
- Takeshima K, Inaba H, Furukawa Y et al (2014) Elevated serum immunoglobulin G4 levels in patients with Graves’ disease and their clinical implications. Thyroid 24:736–743. https://doi.org/10.1089/thy.2013.0448
- Torimoto K, Okada Y, Kurozumi A et al (2017) Clinical features of patients with Basedow’s disease and high serum IgG4 levels. Intern Med 56:1009–1013. https://doi.org/10.2169/internalmedicine.56.7824
- Umehara H, Okazaki K, Kawa S et al (2021) The 2020 revised comprehensive diagnostic (RCD) criteria for IgG4-RD. Mod Rheumatol 31:529–533. https://doi.org/10.1080/14397595.2020.1859710
- Yamamoto M, Nishimoto N, Tabeya T et al (2012) [Usefulness of measuring serum IgG4 level as diagnostic and treatment marker in IgG4-related disease] (Article in Japanese). Nihon Rinsho Meneki Gakkai Kaishi 35:30–37. https://doi.org/10.2177/jsci.35.30
- Yu SH, Kang JG, Kim CS et al (2017) Clinical implications of immunoglobulin G4 to Graves’ ophthalmopathy. Thyroid 27:1185–1193. https://doi.org/10.1089/thy.2017.0126
- Yu Y, Zhang J, Lu G et al (2016) Clinical relationship between IgG4-positive Hashimoto’s thyroiditis and papillary thyroid carcinoma. J Clin Endocrinol Metab 101:1516–1524. https://doi.org/10.1210/jc.2015-3783
DOI: https://doi.org/10.2478/aite-2024-0015 | Journal eISSN: 1661-4917
Language: English
Submitted on: Mar 21, 2024
Accepted on: Jun 20, 2024
Published on: Jul 20, 2024
Published by: Hirszfeld Institute of Immunology and Experimental Therapy
In partnership with: Paradigm Publishing Services
Publication frequency: 1 times per year
Keywords:
Related subjects:
© 2024 Michal Olejarz, Ewelina Szczepanek-Parulska, Aleksandra Krygier, Elzbieta Wrotkowska, Nadia Sawicka-Gutaj, Marek Ruchala, published by Hirszfeld Institute of Immunology and Experimental Therapy
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.